Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 6031 AL 6045

Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field

Shams S, Wahlund LO.

Biomark Med. 2016;10(1):9-18. doi: 10.2217/bmm.15.101. Epub 2015 Dec 7.

Plasma 8-isoPGF2α and serum melatonin levels in patients with minimal cognitive impairment and Alzheimer disease

Sirin FB, Kumbul Doğuç D, Vural H, Eren I, Inanli I, Sütçü R, Delibaş N.

Turk J Med Sci. 2015;45(5):1073-7. doi: 10.3906/sag-1406-134.

[Correlation of mental activity with cognitive functions  in mild cognitive impairment and early stage dementia]

Defrancesco M, Kemmler G, Huber R, Deisenhammer EA.

Nervenarzt. 2014 Mar;85(3):350-5. doi: 10.1007/s00115-013-3738-3.

[The epidemiology of chronic diseases and long-term care: results of a claims data-based study]

van den Bussche H, Heinen I, Koller D, Wiese B, Hansen H, Schäfer I, Scherer M, Glaeske G, Schön G.

Z Gerontol Geriatr. 2014 Jul;47(5):403-9. doi: 10.1007/s00391-013-0519-3.

Efficacy of musical interventions in dementia: evidence from a randomized controlled trial

Narme P, Clément S, Ehrlé N, Schiaratura L, Vachez S, Courtaigne B, Munsch F, Samson S.

J Alzheimers Dis. 2014;38(2):359-69. doi: 10.3233/JAD-130893.

Effects of spaced retrieval training on semantic memory in Alzheimer’s disease: a systematic review

Oren S, Willerton C, Small J.

J Speech Lang Hear Res. 2014 Feb;57(1):247-70. doi: 10.1044/1092-4388(2013/12-0352).

Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives

Polidori MC, Nelles G.

Curr Pharm Des. 2014;20(18):3083-92. doi: 10.2174/13816128113196660706.

Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE

Razavi M, Tolea MI, Margrett J, Martin P, Oakland A, Tscholl DW, Ghods S, Mina M, Galvin JE.

Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):156-61. doi: 10.1097/WAD.0000000000000008.

MM1+2C sporadic Creutzfeldt-Jakob disease presenting as rapidly progressive nonfluent aphasia

Allegri RF, Bartoloni L, Iturry M, Romero C, Begué C, Sevlever G, Taratuto AL.

J Alzheimers Dis. 2014;39(1):13-7. doi: 10.3233/JAD-130350.

Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort

Runtti H, Mattila J, van Gils M, Koikkalainen J, Soininen H, Lötjönen J; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2014;39(1):49-61. doi: 10.3233/JAD-130359.

Use and safety of antipsychotics in behavioral disorders in elderly people with dementia

Gareri P, De Fazio P, Manfredi VG, De Sarro G.

J Clin Psychopharmacol. 2014 Feb;34(1):109-23. doi: 10.1097/JCP.0b013e3182a6096e.

Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS, Petersen RC, Roberts RO.

J Alzheimers Dis. 2014;39(2):271-82. doi: 10.3233/JAD-130830.

Chronic traumatic encephalopathy: a critical appraisal

Levin B, Bhardwaj A.

Neurocrit Care. 2014 Apr;20(2):334-44. doi: 10.1007/s12028-013-9931-1.

Validation and diagnostic utility of the dementia rating scale in a mixed dementia population

McCulloch K, Collins RL, Maestas KL, LeMaire AW, Pacheco V.

Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):168-74. doi: 10.1097/WAD.0000000000000014.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias